Qube Research & Technologies LTD Aspira Women'S Health Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.38 - $1.07 $1,749 - $4,927
-4,605 Reduced 6.59%
65,279 $24,000
Q2 2022

Aug 15, 2022
BUY
$0.4 - $1.09 $27,953 - $76,173
69,884 New
69,884 $41,000

Others Institutions Holding AWH

# of Institutions
2
Shares Held
431K
Call Options Held
0
Put Options Held
0
View Full List

About Aspira Women's Health Inc.

AWH Quotes by TradingView
  • Ticker AWH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 124,296,000
  • Market Cap $123M
  • Description
  • Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...
More about AWH
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email